Antitumor diarylsulfonylureas: Novel agents with unfulfilled promise

被引:33
作者
Houghton, PJ
Houghton, JA
机构
[1] Department of Molecular Pharmacology, St. Jude Children's Research Hospital, Memphis
[2] Dept. Molecular Pharmacology, St Jude Children's Research Hospital, Memphis, TN 38105-2794, N. Lauderdale
关键词
diarylsulfonylureas; xenografts; pharmacology;
D O I
10.1007/BF00194530
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Diarylsulfonylureas represent a class of antitumor agent with significant therapeutic efficacy against rodent and human models of cancer. Despite the exciting preclinical activity of sulofenur, the prototypic agent, clinical activity was poor. Here we review the activity of sulofenur and a second generation diarylsulfonylurea, LY295501 N-[5-(2,3-dihydrobenzofuryl) sulfonyl]-N'-(3,4-dichlorophenyl)urea, against colon tumor xenografts, and some of the cellular pharmacology of this class of antitumor agents.
引用
收藏
页码:271 / 280
页数:10
相关论文
共 34 条
[11]   EFFICACY OF SULOFENUR AND A 2ND-GENERATION DIARYLSULFONYLUREA, N-[5-(2,3-DIHYDROBENZOFURYL)SULFONYL]-N'-(3,4-DICHLOROPHENYL)UREA (LY295501), AGAINST COLON ADENOCARCINOMA XENOGRAFTS [J].
HOUGHTON, PJ ;
CHESHIRE, PJ ;
MYERS, L ;
LUTZ, L ;
TOTH, J ;
GRINDEY, GB ;
HOUGHTON, JA .
ANTI-CANCER DRUGS, 1995, 6 (02) :317-323
[12]  
HOUGHTON PJ, 1990, CANCER RES, V50, P664
[13]   STUDIES ON THE CELLULAR PHARMACOLOGY OF N-(4-METHYLPHENYLSULFONYL)-N'-(4-CHLOROPHENYL)-UREA [J].
HOUGHTON, PJ ;
BAILEY, FC ;
GERMAIN, GS ;
GRINDEY, GB ;
HOWBERT, JJ ;
HOUGHTON, JA .
BIOCHEMICAL PHARMACOLOGY, 1990, 39 (07) :1187-1192
[14]  
HOUGHTON PJ, 1990, CANCER RES, V50, P318
[15]   EVALUATION OF N-(5-INDANYLSULFONYL)-N'-(4-CHLOROPHENYL)-UREA AGAINST XENOGRAFTS OF PEDIATRIC RHABDOMYOSARCOMA [J].
HOUGHTON, PJ ;
HOUGHTON, JA ;
MYERS, L ;
CHESHIRE, P ;
HOWBERT, JJ ;
GRINDEY, GB .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1989, 25 (02) :84-88
[16]   NOVEL AGENTS EFFECTIVE AGAINST SOLID TUMORS - THE DIARYLSULFONYLUREAS - SYNTHESIS, ACTIVITIES, AND ANALYSIS OF QUANTITATIVE STRUCTURE-ACTIVITY-RELATIONSHIPS [J].
HOWBERT, JJ ;
GROSSMAN, CS ;
CROWELL, TA ;
RIEDER, BJ ;
HARPER, RW ;
KRAMER, KE ;
TAO, EV ;
AIKINS, J ;
POORE, GA ;
RINZEL, SM ;
GRINDEY, GB ;
SHAW, WN ;
TODD, GC .
JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (09) :2393-2407
[17]  
MORRIS CJ, 1993, P AM ASSOC CANC RES, V34, pA1743
[18]   A PHASE-II STUDY OF SULOFENUR, A NOVEL SULFONYLUREA, IN RECURRENT EPITHELIAL OVARIAN-CANCER [J].
OBRIEN, MER ;
HARDY, J ;
TAN, S ;
WALLING, J ;
PETERS, B ;
HATTY, S ;
WILTSHAW, E .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1992, 30 (03) :245-248
[19]   SULOFENUR CYTOTOXICITY AND CHANGES IN CYTOSOLIC CALCIUM AND MITOCHONDRIAL-MEMBRANE POTENTIAL IN HUMAN COLON ADENOCARCINOMA CELL-LINES [J].
PHELPS, PC ;
JAIN, PT ;
BEREZESKY, IK ;
BODER, GB ;
TRUMP, BF .
CANCER LETTERS, 1995, 88 (01) :27-35
[20]  
PHELPS PC, 1994, P AM ASSOC CANC RES, V35, pA1916